Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study - Nakamura, Y; Mizuno, N; Sunakawa, Y (J Clin Oncol, 2023)
et al.